Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Stephen G. Swisher, MD
M.D. Anderson Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
97 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Providence Saint Joseph Medical Center - Burbank
Burbank, California, United States
- Saint Rose Hospital
Hayward, California, United States
- Providence Holy Cross Cancer Center
Mission Hills, California, United States
- Ccop - Bay Area Tumor Institute
Oakland, California, United States
- Summit Medical Center
Oakland, California, United States
- Valley Care Medical Center
Pleasanton, California, United States
- J.C. Robinson, M.D. Regional Cancer Center
San Pablo, California, United States
- University of Colorado Cancer Center at University of Colorado Health Sciences Center
Aurora, Colorado, United States
- Hospital of Saint Raphael
New Haven, Connecticut, United States
- Baptist-South Miami Regional Cancer Program
Miami, Florida, United States
- Gulf Coast Cancer Treatment Center
Panama City, Florida, United States
- Curtis & Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center
Savannah, Georgia, United States
- Mount Sinai Hospital Medical Center
Chicago, Illinois, United States
- St. Francis Hospital and Health Centers - Beech Grove Campus
Beech Grove, Indiana, United States
- Wendt Regional Cancer Center at Finley Hospital
Dubuque, Iowa, United States
- Ochsner Clinic of Baton Rouge
Baton Rouge, Louisiana, United States
- Ccop - Ochsner
New Orleans, Louisiana, United States
- Ccop - Michigan Cancer Research Consortium
Ann Arbor, Michigan, United States
- St. Joseph Mercy Cancer Center at St. Joseph Mercy Hospital
Ann Arbor, Michigan, United States
- Oakwood Cancer Center at Oakwood Hospital and Medical Center
Dearborn, Michigan, United States
- Green Bay Oncology, Limited - Escanaba
Escanaba, Michigan, United States
- Genesys Hurley Cancer Institute
Flint, Michigan, United States
- Van Elslander Cancer Center at St. John Hospital and Medical Center
Grosse Pointe Woods, Michigan, United States
- Green Bay Oncology, Limited - Iron Mountain
Iron Mountain, Michigan, United States
- Foote Hospital
Jackson, Michigan, United States
- Sparrow Regional Cancer Center
Lansing, Michigan, United States
- Seton Cancer Institute - Saginaw
Saginaw, Michigan, United States
- St. John Macomb Hospital
Warren, Michigan, United States
- Fairview Ridges Hospital
Burnsville, Minnesota, United States
- Mercy and Unity Cancer Center at Mercy Hospital
Coon Rapids, Minnesota, United States
- Fairview Southdale Hospital
Edina, Minnesota, United States
- Mercy and Unity Cancer Center at Unity Hospital
Fridley, Minnesota, United States
- Virginia Piper Cancer Institute at Abbott-Northwestern Hospital
Minneapolis, Minnesota, United States
- Hubert H. Humphrey Cancer Center at North Memorial Medical Center
Robbinsdale, Minnesota, United States
- Ccop - Metro-Minnesota
Saint Louis Park, Minnesota, United States
- Park Nicollet Health Services
Saint Louis Park, Minnesota, United States
- United Hospital
Saint Paul, Minnesota, United States
- Ridgeview Medical Center
Waconia, Minnesota, United States
- Hattiesburg Clinic, P.A.
Hattiesburg, Mississippi, United States
- Ccop - Cancer Research for the Ozarks
Springfield, Missouri, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2003
- Primary completion
- 31 Mar 2007
- Completion
- 31 Dec 2016
- Last update posted
- 17 Feb 2017
- Registered enrollment
- 43
- Registry id
- NCT00069953
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.